FDA Cites Pneumex in Warning Letter

A July inspection resulted in these conclusions.

The FDA has cited rehabilitation equipment manufacturer Pneumex in a December warning. These conclusions are based on a July inspection at the Idaho plant:

 • Failure to implement design and development plans for the Vibro-Trac table

• Failure to document or approve design input requirements for the Vibro-Trac table

• Failure to maintain production records on the Pneu-Back Chair since 2004

• Failure to perform “quality audits” on any devices since 2004

• Failure to designate an individual to review and approve documents 

See the warning letter at compliancefda.com/ShowExternHTML.aspF=CFDAs7061c&src=RSS.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters